OBJECTIVE： To investigate the role of clinical pharmacists in the therapy for patient with pulmonary aspergillosis complicated with rhabdomyolysis （RM）. METHODS： Clinical pharmacists participated in the therapy for RM patients with pulmonary aspergillosis， and assisted physicians to optimize and improve therapy plan from RM therapy， anti-infection and liver protection： stop taking Bicyclol tablet， continue Micafungin for injection 50 mg， ivgtt， qd for anti-infection； suspend liver-protective drug Compound glycyrrhizin； closely monitor therapeutic efficacy and ADR. RESULTS： Physicians adopted the suggestions of clinical pharmacists， and the situation of RM were improved. The patient were discharged from hospital 24 d later. CONCLUSIONS： Clinical pharmacists participate in therapy for RM patient with pulmonary aspergillosis and assist physicians to improve therapy plan， which contribute to rational drug use and the safety of drug use.